Carcinoid heart disease: Current understanding and future directions

Chirdeep Patel, Moses Mathur, Ricardo O. Escarcega, Alfred A. Bove

Research output: Contribution to journalReview articlepeer-review

44 Scopus citations


Carcinoid tumors are rare and aggressive malignancies. A multitude of vasoactive agents are central to the systemic effects of these tumors. The additional burden of cardiac dysfunction heralds a steep decline in quality of life and survival. Unfortunately, by the time carcinoid syndrome surfaces clinically, the likelihood of cardiac involvement is 50%. Although medical therapies such as somatostatin analogues may provide some symptom relief, they offer no mortality benefit. On the other hand, referral to surgery following early detection has shown increased survival. The prompt recognition of this disease is therefore of the utmost importance.

Original languageEnglish (US)
Pages (from-to)789-795
Number of pages7
JournalAmerican Heart Journal
Issue number6
StatePublished - Jun 2014

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Carcinoid heart disease: Current understanding and future directions'. Together they form a unique fingerprint.

Cite this